ARMISTICE CAPITAL, LLC — 13F holdings
ARMISTICE CAPITAL, LLC reported 341 holdings worth $8.17B in its 13F filing for Q2 2026, filed August 14, 2026.
Largest positions
- SPY SPDR S&P 500 ETF TR — $2.39B (29.2%)
- IWM ISHARES TR — $1.74B (21.3%)
- CYTK CYTOKINETICS INC — $233M (2.8%)
- AGIO Agios Pharmaceuticals Inc — $193M (2.4%)
- MDGL MADRIGAL PHARMACEUTICALS INC — $155M (1.9%)
- PTCT PTC THERAPEUTICS INC — $141M (1.7%)
- SUPN SUPERNUS PHARMACEUTICALS INC — $123M (1.5%)
- TVTX TRAVERE THERAPEUTICS INC — $118M (1.4%)
- IMVT Immunovant Inc — $113M (1.4%)
- INCY INCYTE CORP — $102M (1.2%)